LEADER 04151nam  22006615  450 
001 9910373912903321
005 20220601202533.0
010   $a3-030-29768-3
024 7 $a10.1007/978-3-030-29768-8
035   $a(CKB)4100000009938034
035   $a(MiAaPQ)EBC5983989
035   $a(DE-He213)978-3-030-29768-8
035   $a(PPN)260301019
035   $a(EXLCZ)994100000009938034
100   $a20191122d2019      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNanotheranostics $eApplications and Limitations /$fedited by Mahendra Rai, Bushra Jamil
205   $a1st ed. 2019.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019.
215   $a1 online resource (413 pages)
311   $a3-030-29767-5 
327   $aNanotheranostics:An emerging nanoscience -- Green bionanomaterials: current status and future prospects in theranostics -- Current status and prospects of Chitosan?metal Nanoparticles and their applications as theranostic agents -- Aptamersnano complexes and aptamer based biosensors? role in ultrasensitive sensing -- Nanotheranostics Approaches In Antimicrobial Resistance -- Nanomaterials for selective targeting of intracellular pathogens -- Impact of nanoformulations on viruses and bacteria -- Theranostic potential of aptamers in antimicrobial chemotherapy -- Current and future aspects of nanotheranostics in cancer therapeutics -- Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Cancer Theranostic applications -- Theranostic applications of Nanobiotechnology in Cancer -- Aminolevulinic acid associated with nanotechnology for theranostic applications -- Non-viral targeted gene delivery for inflammatory disorder: applications and limitation. .
330   $aThis book is specifically designed to provide information about various nanocarriers currently developed under the emerging field of nanotheranostics for a sustained, controlled, and targeted co-delivery of diagnostic and therapeutic agents. Diverse theranostic applications of nanotechnology and their limitations are also addressed. It integrates nanobiotechnology with theranostic applications. The combined term nanotheranostics has diverse application particularly in chemotherapy and other infectious diseases.Among other topics addressed are antimicrobial resistance, targeting intra-cellular pathogens, viruses and bacteria, chemotherapy, cancer therapeutics, and inflammatory disorders. This interdisciplinary volume, Nanotheranostics, Applications and Limitations, is essential for a diverse group of readers including nanotechnologists, microbiologists, biotechnologists, bioengineering and bioprocess industry. .
606   $aPharmacology
606   $aNanochemistry
606   $aCancer$xResearch
606   $aChemotherapy
606   $aNanotecnologia$2thub
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
606   $aNanochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/C33000
606   $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001
606   $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000
606   $aUltraestructura (Biologia)$2thub
608   $aLlibres electrònics$2thub
615  0$aPharmacology.
615  0$aNanochemistry.
615  0$aCancer$xResearch.
615  0$aChemotherapy.
615  7$aNanotecnologia
615 14$aPharmacology/Toxicology.
615 24$aNanochemistry.
615 24$aCancer Research.
615 24$aPharmacotherapy.
615   $aUltraestructura (Biologia)
676   $a610.28
702   $aRai$b Mahendra$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aJamil$b Bushra$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910373912903321
996   $aNanotheranostics$91913530
997   $aUNINA